Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 344,865 | 358,328 | 161,900 | 341,246 | 268,269 |
| Marketable Securities | 252,652 | 173,850 | 217,271 | 96,850 | 2,993 |
| Receivables | 104,746 | 42,040 | N/A | N/A | N/A |
| Inventories | 26,508 | 6,985 | N/A | N/A | N/A |
| TOTAL | $742,045 | $587,909 | $383,779 | $442,267 | $275,058 |
| Non-Current Assets | |||||
| PPE Net | 155,168 | 161,202 | 161,684 | 112,355 | 30,876 |
| Investments And Advances | 152,114 | 61,954 | 4,621 | 64,371 | 0 |
| Other Non-Current Assets | 6,511 | 7,290 | 8,366 | 7,302 | 4,910 |
| TOTAL | $313,793 | $230,446 | $174,671 | $184,028 | $35,786 |
| Total Assets | $1,055,838 | $818,355 | $558,450 | $626,295 | $310,844 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,985 | 4,132 | 3,981 | 8,398 | 2,105 |
| Accrued Expenses | 95,793 | 27,488 | 23,305 | 16,297 | 5,109 |
| TOTAL | $101,995 | $33,094 | $28,847 | $25,736 | $15,452 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,463 | 6,620 | 7,372 | 6,983 | 3,308 |
| TOTAL | $7,463 | $6,620 | $7,372 | $6,983 | $3,308 |
| Total Liabilities | $109,458 | $39,714 | $36,219 | $32,719 | $18,760 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,806 | 28,293 | 25,764 | 25,208 | 22,195 |
| Retained earnings | -180,668 | -269,827 | -280,759 | -140,784 | -71,214 |
| Other shareholders' equity | -190 | 638 | -728 | -163 | 6 |
| TOTAL | $946,380 | $778,641 | $522,231 | $593,576 | $292,084 |
| Total Liabilities And Equity | $1,055,838 | $818,355 | $558,450 | $626,295 | $310,844 |